{"type":"profile","id":"profile=medica2026.3078661","exhSeoId":"B1SsxHNVT3KyZObmfaK6MQ","name":"HEMO BIOENGINEERING PTE. LTD.","email":"enquire@hemocorp.com","getInTouchEmail":"enquire@hemocorp.com","profileAddress":{"address":["10, Ubi Crescent, #05-45, Ubi Techpark"],"city":"Singapore","zip":"408564","pobox":"singapore","poboxZip":"417941","country":"Singapore","countryCode":"SG","zip_pobox":"417941"},"phone":{"phone":"+65 69 806411"},"links":[{"id":"link=1SqmxWqFQNK0CqzzMaowng","type":"link","link":"https://www.hemocorp.com","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[{"id":"video=0ZPkQeJDRlih5cH42ciegA","type":"video","title":"Neuro Trinity","parentType":"profile","videoId":"1225554754","videoBlindSuitable":false,"videoDeafSuitable":false,"videoUploaded":true,"videoHasTexttrack":false,"order":1,"visibleInLang":["en","de"]}],"locations":[{"areaId":"10","area":"Hall 10","stand":"F70"}],"location":"Hall 10 / F70","locationIsVirtual":false,"events":[{"key":"medica2026","label":"MEDICA 2026"}],"eventIcons":[{"label":"MEDICA 2026","src":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/medica2026/3078661.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/medica2026/10/3078661.svg","areaId":"10","premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[{"id":"tag=medica2026.0","label":"Manufacturer","icon":"md md-tag-label md-tag-label-m"}],"xtags":[],"socialMedia":[{"title":"LinkedIn","link":"https://www.linkedin.com/company/hemobioeng/","network":"linkedin","standardDomain":"https://www.linkedin.com/"}],"synonyms":[],"text":"<p>Headquartered in Singapore, <strong>HEMO Bioengineering</strong> is an innovative medical device company focused on developing advanced solutions for <strong>neuro-interventional treatment</strong>. Our mission is to improve patients&#8217; health and quality of life through innovative, clinically relevant medical technologies.</p><p>HEMO has built a comprehensive portfolio of <strong>neuro-interventional medical devices</strong> covering <strong>ischemic stroke, hemorrhagic stroke and neurovascular access</strong>. Among our key innovations is <strong>AsprAX™</strong>, a super large-bore aspiration catheter designed to support mechanical thrombectomy procedures and representing one of the largest-bore aspiration catheter platforms commercialized outside the United States.</p><p>With corporate, R&#38;D and production capabilities across <strong>Singapore, China, the United States and Malaysia</strong>, HEMO combines global product development expertise with an expanding international commercial presence across <strong>Europe, Asia and the Middle East</strong>. Our R&#38;D activities are further supported by a network of key opinion leaders, clinicians and industry experts who provide valuable insights into clinical needs and product development.</p><p>HEMO's leadership team comprises experienced professionals from the global medical device industry, including veterans of established multinational and Fortune 500 companies. The Group was founded by <strong>Chairman Professor Jack Wang</strong>, an experienced medtech entrepreneur who previously served as CEO of SGX Mainboard-listed Biosensors International Group and JW Medical Systems.</p><p>HEMO operates under an <strong>EN ISO 13485-certified quality management system</strong> and maintains medical device production capabilities supported by certified controlled-environment facilities. Our neuro-interventional portfolio includes products with <strong>CE MDR certification</strong>, supporting their commercialization in the European market and other international markets.</p><p>In addition to developing and commercializing our proprietary neuro-interventional technologies, HEMO is open to <strong>manufacturing and strategic product partnerships</strong>, including manufacturing support for established medical devices and collaboration with international medical device companies seeking experienced development and production capabilities.</p><p>Through continuous innovation, international collaboration and a strong focus on unmet clinical needs, HEMO aims to become a trusted global partner in the advancement of <strong>neurovascular intervention</strong>.</p>","businessData":[{"id":"founded","type":"year","title":"Foundation","values":[{"id":"founded","label":"2017"}]}],"pdfs":[{"id":"paper=zkHwSdFQRTSJIECnASfEsQ","type":"paper","title":"AsprAX Brochure","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3078661/MEDICA-2026-HEMO-BIOENGINEERING-PTE.-LTD.-Paper-medica2026.3078661-Mzo3nUdAQJmpMjQsJgxRJQ.pdf","parentType":"profile","fileName":"AsprAX Brochure.pdf","order":1,"visibleInLang":["en","de"]},{"id":"paper=eaaznAaJQMGnhhXSpbMhPA","type":"paper","title":"CerebrAX Brochure","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3078661/MEDICA-2026-HEMO-BIOENGINEERING-PTE.-LTD.-Paper-medica2026.3078661-wq8BkH16RLeK8WQAIAheNA.pdf","parentType":"profile","fileName":"CerebrAX Brochure.pdf","order":2,"visibleInLang":["en","de"]}],"tol":["medica2026.01.03.06"],"categories":[{"id":"prod=medica2026.01.03.06","label":"Neurology & neurosurgery","catalogIndex":"01.03.06","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=aNFudmEdQ6WwbO7HpTqNEg","label":"AsprAX Aspiration Catheter"},{"id":"prodinfo=fMAB6eF3SHyRbrT3dFmaYQ","label":"CerebrAX Stent Retriever"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.03","label":"Medical Devices & Clinical Equipment"},{"id":"01.03.06","label":"Neurology & neurosurgery"}]}],"write":false,"lastModified":"2026-11-03T22:35:54Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}